Cover Image

AN UNUSUAL PRESENTATION OF WILSON'S DISEASE

SANDHYA SUNDARARAJAN

Abstract


Abstract :

        Wilson's disease is a neurodegenerative disease of   copper metabolism. Normal dietary consumption and       absorption of copper exceed the metabolic need, and       homeostasis of this element is maintained exclusively by the biliary excretion of copper. In Wilson's disease, the defective biliary excretion of copper leads to its accumulation,          particularly in liver and brain. The deposition of copper in tissues is the cause of virtually all the manifestations of the disease - cirrhosis, hemolytic anemia, renal tubular changes, Kayser-Fleischer rings and the cerebral damage. Here we present a case report of a young girl who presented to us with sudden onset of neuropsychiatric symptoms such as         involuntary twisting movements, abnormal postures and    cognitive impairment but without any form of hepatic        involvement - a fairly uncommon presentation of a rather familiar disease. Achieving a diagnosis of Wilson's disease is dependent on maintaining a high index of suspicion. This is very important because early initiation of treatment will cause significant reduction in morbidity and  mortality. Untreated Wilson's disease is universally fatal, with most patients dying from liver disease and a minority from complications of     progressive neurologic disease.

 

Keyword :Dystonia , Wilson's disease, Kayser Fleischer ring, Sunflower cataract.

 


Full Text:

PDF

References


Harrison’s Principles of Internal Medicine, 18th Ed.

Walshe JM The Conquest of Wilson’s disease. Brain 2009;

Das S K and Ray K.Wilson's disease: an update.Nature Clinical Practice Neurology 2006: 2; 482- 493.

Sherlock S and Dooley J (Eds; 2002) Wilson disease.

Walshe JM. Copper: its role in the pathogenesis of liver disease.Semin Liver Dis. Aug 1984; 4 (3):252- 63.

P. Ferenci.Diagnosis and Current Therapy of Wilson's Disease.Aliment Pharmacol Ther2004;19 (2):157-165.

Cairns JE, Williams HP, Walshe JM. ‘‘Sunflower cataract’’ in Wilson’s disease. Br Med J 1969;3:95–96

Ferenci P, Caca K, Loudianos G, et al. Diagnosis and phenotypic classification of Wilson disease. Final report of the Proceedings of the Working Party at the 8th International Meeting on Wilson Disease and Menkes Disease, Leipzig/Germany, 2001. Liver Int 2003; 23: 139-42.

Brewer GJ, Yuzbasiyan-Gurkan V, Young AB. Treatment of Wilson’s disease. Semin Neurol 1987;7:209–220.

Brewer GJ, Dick RD, Johnson V, Wang Y, Yuzbasiyan-Gurkan V, Kluin K, et al. Treatment of Wilson’s disease with ammonium tetrathiomolybdate: I. Initial therapy in 17 neurologically affected patients. Arch Neurol 1994;51:545–554.

Fryer MJ. Potential of vitamin E as an antioxidant adjunct in Wilson’s disease. Med Hypotheses 2009;73:1029–1030


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An initiative of The Tamil Nadu Dr M.G.R. Medical University